By Donald Zuhn --
On last Thursday's "Colbert Report," host Stephen Colbert turned his attention to the Association of Molecular Pathology v. U.S. Patent and Trademark Office case that was decided on March 29. Pointing to the result in the BRCA1/2 gene patent case, Mr. Colbert said he had found "a reason to be disappointed in the Federal benchwarmers," and noted that the decision would be "a huge blow to the biotech industry." The Comedy Central comedian said that he was "furious at the ACLU," and instead was "with Kevin Noonan here . . . the man who defended Myriad's right to patent the genes." By defending Myriad, Mr. Colbert was referring not to the District Court litigation, but rather Dr. Noonan's appearance on "60 Minutes" earlier this month (see "'60 Minutes' and 'Newshour' Take Different Approaches to Covering Gene Patenting Story"). Mr. Colbert then played the portion of Dr. Noonan's interview in which he argues that patents are necessary in order to promote investment. Now, Patent Docs is well aware that the "Colbert Report" is a satire of news shows that can be found on a certain conservative cable network, and that there is a possibility that Mr. Colbert may actually side with the plaintiffs and the ACLU. However, when one strips away the jokes, the segment still makes a good case for gene patenting (or at least a better case than "60 Minutes") -- other than the part about 401 Man Seed knock-offs, of course.
"Colbert Report" segment on gene patenting can be viewed below:
|The Colbert Report||Mon - Thurs 11:30pm / 10:30c|
|Formula 01 Liquid Genetic Material|